That's correct. It was double-blinded. The electrical impulses were close to the sensation threshold, so both the control and active groups found it difficult to tell if they were getting the somatosensory input. See here. If you stick an electrode on the back of your neck and are told that the stimulation will barely feel, I guarantee you will genuinely think you feel a faint buzz.If I remember correctly, the active arm received electrical impulses so faintly that the participant soon habituated to them and did not feel them. In essence, they were blinded to whether or not they had active or placebo treatment. That's how Dr. Shore explained her blinding.
I heard an explanation that made sense to me. Dr. Shore couldn't get her device picked up by 'big pharma,' who could get this through FDA approval quickly, because the patent isn't strong enough to stand up to a patent challenge. It seems that synchronized signal timing may not be proprietary enough to uphold the patent and may not withstand a legal challenge. So, instead, she had to form her own company with Pearson at the helm. However, he seems inexperienced at FDA matters and is probably fumbling through an FDA submission and learning as he goes.Auricle just needs to get in touch with Purdue Pharma. They'll get it through the FDA without a hitch. **cough** OxyContin **cough**
Check the attached screenshot. This is the job description for the new Auricle employee on LinkedIn. To me, this suggests they are working on a take-home device. Something else seems to be mentioned in the second paragraph, which I think might be related to radiation, but I'm not entirely sure.You are not getting this confused with the Bionics Institute technology, are you? They are looking at several more portable prototypes. I've heard nothing of new prototypes for Auricle.
In various places in the study, study charts, the Q&A, and even the recent webinar from Dr. Shore, the placebo/control/sham is stated as being auditory only. Only one place in some supplemental documentation does it mention a sham timing.I think Dr. Shore's placebo was related to the timing.
This was a little dark humor, not an actual suggestion. I guess for those who aren't familiar with Purdue Pharma and the US OxyContin epidemic - and just basically the FDA to the pharmaceutical executive pipeline.Auricle just needs to get in touch with Purdue Pharma. They'll get it through the FDA without a hitch. **cough** Oxycontin **cough**
If only. I think we have to wait till Pearson puts his big-boy pants on.Are we there yet?
Four years as CEO of Auricle Inc., and what has Pearson actually accomplished? Nothing, as far as anyone can tell. That's why more and more people are turning to their "personal projects" to treat their tinnitus!If only. I think we have to wait till Pearson puts his big-boy pants on.
Those who seek out their own path are the real heroes—not Pearson. How did he even get the job? He has no prior experience in launching any health-related global medical devices and clearly lacks an understanding of the consumer. Yet, he has been handed this multimillion-dollar opportunity. I don't want my money going to this guy. Frankly, by the time they get anything up and running, other treatments will likely be available, so hopefully, I won't have to rely on him.Four years as CEO of Auricle Inc., and what has Pearson actually accomplished? Nothing, as far as anyone can tell. That's why more and more people are turning to their "personal projects" to treat their tinnitus!
Nepotism.How did he even get the job? He has no prior experience in launching any health-related global medical devices and clearly lacks an understanding of the consumer. Yet, he has been handed this multimillion-dollar opportunity.
Is Susan Shore really going to let 20 years of research go to waste? Has it truly been abandoned? If so, why did she host that webinar back in June? It's hard to believe. She could leave behind a great legacy, but it seems like she doesn't care—or at least that's the impression I get.Auricle is a dead horse now. Beyond science, Pearson's incompetence will make it explode. It's a succession of red flags without the slightest positive sign.
Even if he manages to bring it to market in several years, there will likely be better treatments available by then, or the patent will have expired.
Not abandoned. Just moving through the halls of bureaucracy at a snail's pace.Is Susan Shore really going to let 20 years of research go to waste? Has it truly been abandoned? If so, why did she host that webinar back in June? It's hard to believe. She could leave behind a great legacy, but it seems like she doesn't care—or at least that's the impression I get.
There are already numerous treatments that people on Tinnitus Talk can attest to. None of them work for everyone because, as we all know, every case of tinnitus is different. Yes, there are classifications and common symptoms associated with different types and causes of tinnitus, but if it were as simple as having one single cause, there would likely be a definitive cure.Auricle is a dead horse now. Beyond science, Pearson's incompetence will make it explode. It's a succession of red flags without the slightest positive sign.
Even if he manages to bring it to market in several years, there will likely be better treatments available by then, or the patent will have expired.
The Shore device is the only treatment that will reduce tinnitus volume. That's the treatment everyone needs. It's never been possible before until this device becomes available.There are already numerous treatments that people on Tinnitus Talk can attest to. None of them work for everyone because, as we all know, every case of tinnitus is different. Yes, there are classifications and common symptoms associated with different types and causes of tinnitus, but if it were as simple as having one single cause, there would likely be a definitive cure.
My point is that many people have found relief through various treatments. Some have benefited from certain supplements, Cognitive Behavioral Therapy (CBT), alternative medications, electrical stimulation, cochlear implants, and a myriad of other options. The number of available treatments is steadily growing, though progress is slow.
However, the slow pace of advancements and the fact that, according to Dr. Shore, this treatment is only being tested on those with somatic tinnitus, makes me skeptical that it will be the universal "magic bullet" many hope for.
I'm not sure if there are different types of tinnitus. I believe the condition is essentially the same for everyone, but what varies is the severity, duration, and how each person experiences it. For example, a person with hearing loss who doesn't use hearing aids to improve their hearing may perceive their tinnitus less, but that doesn't necessarily mean the tinnitus itself decreases. I think what works for one person may work for others, with the main difference being how long they've had tinnitus.There are already numerous treatments that people on Tinnitus Talk can attest to. None of them work for everyone because, as we all know, every case of tinnitus is different. Yes, there are classifications and common symptoms associated with different types and causes of tinnitus, but if it were as simple as having one single cause, there would likely be a definitive cure.
My point is that many people have found relief through various treatments. Some have benefited from certain supplements, Cognitive Behavioral Therapy (CBT), alternative medications, electrical stimulation, cochlear implants, and a myriad of other options. The number of available treatments is steadily growing, though progress is slow.
However, the slow pace of advancements and the fact that, according to Dr. Shore, this treatment is only being tested on those with somatic tinnitus, makes me skeptical that it will be the universal "magic bullet" many hope for.
It might not be the only treatment.The Shore device is the only treatment that will reduce tinnitus volume. That's the treatment everyone needs. It's never been possible before until this device becomes available.
There are two components to the etiology of tinnitus: the peripheral issue and the central generation. TMJ dysfunction and Meniere's disease are fundamentally different conditions, so it's reasonable to consider their resulting tinnitus as having different etiologies. However, the tinnitus is still being generated centrally, possibly by fusiform cells in the dorsal cochlear nucleus (DCN), as proposed in Dr. Shore's model.This "different types of tinnitus" perspective is what has ultimately led to "muh heterogeneity" and the endless conveyor belt of clinical researchers all needing "another ten years" and a horde of gerbils.
The solution to tinnitus starts with one decent executive project manager. If these well-funded institutional players don't start getting on with it, I think citizen science will eventually take over.
I believe you're wrong. Each person's case is as unique as a fingerprint. Sound, intensity, and every other factor vary from individual to individual. The only thing common to all is the source - the DCN, and the cause - hyperactive fusiform cells.I'm not sure if there are different types of tinnitus. I believe the condition is essentially the same for everyone, but what varies is the severity, duration, and how each person experiences it. For example, a person with hearing loss who doesn't use hearing aids to improve their hearing may perceive their tinnitus less, but that doesn't necessarily mean the tinnitus itself decreases. I think what works for one person may work for others, with the main difference being how long they've had tinnitus.
Somehow, I'm cheered by the simplicity of your summary — but let me just play that through one more time.I believe you're wrong. Each person's case is as unique as a fingerprint. Sound, intensity, and every other factor vary from individual to individual. The only thing common to all is the source - the DCN, and the cause - hyperactive fusiform cells.
I'm a person with hearing loss who doesn't use hearing aids to improve my hearing. But I perceive my tinnitus louder, not less. The tinnitus stands out even more when the environmental sounds are quieter due to hearing loss. Hearing aids amplify actual sounds, not tinnitus. So they can create more of a masking effect by amplifying external sounds while the tinnitus maintains its same internal level. I just met with an audiologist and might be trying some out soon.For example, a person with hearing loss who doesn't use hearing aids to improve their hearing may perceive their tinnitus less, but that doesn't necessarily mean the tinnitus itself decreases.
I couldn't catch it, but I will listen in due course. I would be very surprised if Dr. Langguth has inside information on Auricle, given their lack of communication. I recall Dr. Shore mentioning after the second trial that the focus would shift to commercialization and that the next studies would involve real-life feedback. She also indicated that she had worked with the FDA during the trial process, suggesting that they provided guidelines for conducting an appropriate trial. The FDA often gets a reputation for being a hindrance, but in Dr. Lim's interview, he described them as helpful and collaborative.Did anyone listen to Dr. Berthold Langguth on the Tinnitus Quest Q&A webinar, especially the part where he said we won't know how effective Dr. Shore's device will be until a larger trial is completed?
Has anyone managed to get a hold of this?In Supplement 3, it states you can request depersonalized individual participant data from Dr. Shore but you need to have an academic or clinical interest and that it's to be used for future research. I'm not sure if we have anyone on here who would qualify.
I thought the above was interesting. Right at the beginning of the thread.She and her colleagues are also working to develop pharmacological manipulations that could enhance stimulus timed plasticity by changing specific molecular targets.
But, she notes, any treatment will likely have to be customized to each patient, and delivered on a regular basis. And some patients may be more likely to derive benefit than others.
I feel like that's a necessary disclaimer. Many people experience strong anxiety related to their tinnitus, and a reduction in volume might not seem significant to everyone. Additionally, since we cannot measure the extent of damage in individuals, it's reasonable to hypothesize that those with tinnitus and more extensive damage may not experience improvement or may have other factors that make them less likely to respond to treatment.I thought the above was interesting. Right at the beginning of the thread.